The U.S. Food and Drug Administration today approved a new use for Xiaflex (collagenase clostridium histolyticum) as the first FDA-approved medicine to treat men with bothersome curvature of the penis, a condition known as Peyronie’s disease.
The U.S. Food and Drug Administration today approved a new use for Xiaflex (collagenase clostridium histolyticum) as the first FDA-approved medicine to treat men with bothersome curvature of the penis, a condition known as Peyronie’s disease.
Two medications are licensed in the United States for the treatment of infection with genital herpes simplex virus (HSV): valacyclovir (approved by the Food and Drug Administration in 1995) and famciclovir (approved in 1997).
Obstructive sleep apnea is a common disorder, characterized by recurrent narrowing and closure of the upper airway accompanied by intermittent oxyhemoglobin desaturation and sympathetic activation.1
Two medications are licensed in the United States for the treatment of infection with genital herpes simplex virus (HSV): valacyclovir (approved by the Food and Drug Administration in 1995) and famciclovir (approved in 1997).
Question
If a patient in the emergency department can't communicate, is it a HIPAA violation to call a pharmacy to get medical information?
Response from Carolyn Buppert, MSN, JD Healthcare attorney, Boulder, Colorado |
ISSUE: FDA is warning the public that the anti-seizure drug Onfi (clobazam) can cause rare but serious skin reactions that can result in permanent harm and death. FDA approved changes to the Onfi drug label and the patient Medication Guide to describe the risk of these serious skin reactions.
Selective serotonin reuptake inhibitors (SSRIs) are increasingly used in the treatment of depression and anxiety disorders.
又一年過去了,是的,又到了總結時間了
The latest update on best practices from the American College of Gastroenterology
Acute liver failure is a rare but life-threatening critical illness that occurs most often in patients who do not have preexisting liver disease.
之前也有跟各位討論過:
ACEI與ARB併用之討論
來看看另外的觀點
Hello. This is Jeffrey Berns, Editor-in-Chief of Medscape Nephrology.